SEC Seeks To Bar Milbank Probe From Dialysis Execs' Trial
By Brian Dowling · January 6, 2025, 5:30 PM EST
The U.S. Securities and Exchange Commission said Monday that two dialysis company executives accused of accounting fraud should not be allowed to tell a jury about a Milbank LLP-led internal investigation...
To view the full article, register now.